|
|
|
Insider
Information: |
Sigal Elliot |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
148,221 |
|
Indirect Shares
|
78,638 |
|
|
Direct
Value |
$5,965,895 |
|
|
Indirect Value
|
$5,479,085 |
|
|
Total
Shares |
226,859 |
|
|
Total
Value |
$11,444,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-06 |
4 |
D |
$24.60 |
$78,400 |
D/D |
(3,187) |
193,339 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-07 |
4 |
D |
$24.60 |
$87,428 |
D/D |
(3,554) |
189,785 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-04-30 |
4 |
OE |
$24.74 |
$7,641,575 |
D/D |
305,905 |
459,398 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-05-30 |
4 |
OE |
$24.74 |
$4,495,081 |
D/D |
170,625 |
276,514 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2006-11-01 |
4 |
D |
$24.76 |
$75,221 |
D/D |
(3,038) |
180,108 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-12-04 |
4 |
GD |
$25.14 |
$125,700 |
D/D |
5,000 |
165,634 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-15 |
4 |
S |
$25.94 |
$1,233,784 |
D/D |
(47,563) |
142,222 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-07 |
4 |
D |
$26.31 |
$93,506 |
D/D |
(3,554) |
211,238 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2007-03-02 |
4 |
D |
$26.42 |
$25,865 |
D/D |
(979) |
174,941 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-04 |
4 |
D |
$26.43 |
$91,316 |
D/D |
(3,455) |
211,104 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-06 |
4 |
D |
$26.43 |
$84,232 |
D/D |
(3,187) |
214,792 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4 |
D |
$27.01 |
$28,415 |
D/D |
(1,052) |
176,153 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4 |
A |
$27.01 |
$61,151 |
D/D |
2,264 |
177,205 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4/A |
D |
$27.01 |
$28,415 |
D/D |
(1,052) |
176,153 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
|
2007-03-06 |
4/A |
A |
$27.01 |
$61,151 |
D/D |
2,264 |
177,205 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-06-03 |
4 |
OE |
$27.01 |
$2,670,614 |
D/D |
98,875 |
231,868 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-09-20 |
4 |
D |
$27.81 |
$214,860 |
D/D |
(7,726) |
134,496 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
|
2004-02-20 |
4 |
D |
$28.41 |
$30,001 |
D/D |
(1,056) |
98,968 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
D |
$28.70 |
$4,313,747 |
D/D |
(150,299) |
205,902 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
OE |
$28.70 |
$5,326,321 |
D/D |
185,579 |
356,931 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
S |
$28.70 |
$20,952 |
D/D |
(730) |
356,201 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
D |
$28.90 |
$6,609,201 |
D/D |
(228,681) |
171,352 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
S |
$28.90 |
$2,046,265 |
D/D |
(70,805) |
372,572 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
OE |
$28.90 |
$7,502,803 |
D/D |
259,600 |
470,838 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2007-11-01 |
4 |
D |
$29.16 |
$112,908 |
D/D |
(3,872) |
168,410 |
0 |
- |
|
133 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|